March 26, 2020
On March 25, Bill C-13, the COVID-19 Emergency Response Act, received Royal Assent that includes amendments to both the Patent Act and the Food and Drugs Act to ensure the availability of drugs and medical devices.
March 17, 2020
On Friday, March 13, the House of Commons and the Senate approved the new USMCA within hours of each other.
January 20, 2020
With the changing of demographics and shifting in attitudes, the onboarding
process can never be a static situation and should be
reviewed on an ongoing basis.
December 24, 2019
So where are we regarding timing before the flood gates open?
December 17, 2019
It has taken significant time to mend the relationship between pharmacy and the Ontario government since the 2010 pharmacy rallies at Queen’s Park in response to the elimination of professional allowances.
December 13, 2019
This was not a surprise as rumblings about Alberta taking the biosimilars plunge had been circulating for a few months.
December 12, 2019
While the changes to the PSP funding may not be a surprise to some given the growing lens of transparency within the industry, this revision could have significant implications.
November 28, 2019
Loss of exclusivity requires alot of effort with minimal financial reward for maintaining the life of a brand.
November 22, 2019
The Draft PMPRB Guidelines were released yesterday to explain how the amended Patented Medicines Regulations, that go into effect July 1, 2020 will be implemented.
November 12, 2019
Forteo (teriparatide, Lilly) is a biologic manufactured using recombinant DNA technology.